{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:20:31Z","timestamp":1770974431098,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001734","name":"University of Copenhagen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011748","name":"Phospholipid Research Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011748","id-type":"DOI","asserted-by":"crossref"}]},{"name":"EU FP7 CALIPSO","award":["312284"],"award-info":[{"award-number":["312284"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jconrel.2017.03.393","type":"journal-article","created":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T21:31:25Z","timestamp":1490909485000},"page":"45-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["In vitro and in vivo performance of monoacyl phospholipid-based self-emulsifying drug delivery systems"],"prefix":"10.1016","volume":"255","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1974-9540","authenticated-orcid":false,"given":"Thuy","family":"Tran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scheyla D.V.S.","family":"Siqueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Amenitsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3020-8892","authenticated-orcid":false,"given":"Anette","family":"M\u00fcllertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Rades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.03.393_bb0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejps.2007.05.110","article-title":"When poor solubility becomes an issue: from early stage to proof of concept","volume":"31","author":"Stegemann","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0010","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/j.2042-7158.2010.01107.x","article-title":"New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs","volume":"62","author":"M\u00fcllertz","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijpharm.2016.02.026","article-title":"Formulation and characterization of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine","volume":"502","author":"Tran","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0020","article-title":"Monoacyl phosphatidylcholine inhibits the formation of lipid multilamellar structures during in vitro lipolysis of self-emulsifying drug delivery systems","author":"Tran","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0025","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/gut.26.4.369","article-title":"Lysophosphatidylcholine increases rat ileal permeability to macromolecules","volume":"26","author":"Tagesson","year":"1985","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2017.03.393_bb0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0378-5173(94)00232-T","article-title":"Drug delivery studies in Caco-2 monolayers. II. Absorption enhancer effects of lysophosphatidylcholines","volume":"114","author":"Hovgaard","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0035","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/jps.2600830336","article-title":"Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation","volume":"83","author":"Kovarik","year":"1994","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0040","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1018923912135","article-title":"Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation","volume":"11","author":"Mueller","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0045","first-page":"591","article-title":"Clinical studies with oral lipid based formulations of poorly soluble compounds","volume":"3","author":"Fatouros","year":"2007","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0050","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1021\/acs.molpharmaceut.5b00784","article-title":"In vivo formation of cubic phase in situ after oral administration of cubic phase precursor formulation provides long duration gastric retention and absorption for poorly water-soluble drugs","volume":"13","author":"Pham","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0055","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s11095-008-9641-0","article-title":"Lipid-based formulations for danazol containing a digestible surfactant, Labrafil M2125CS: In vivo bioavailability and dynamic in vitro lipolysis","volume":"25","author":"Larsen","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0060","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s11095-015-1829-5","article-title":"The precipitation behavior of poorly water-soluble drugs with an emphasis on the digestion of lipid based formulations","volume":"33","author":"Khan","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0065","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1007\/s11095-013-0999-2","article-title":"Insights into drug precipitation kinetics during in vitro digestion of a lipid-based drug delivery system using in-line Raman spectroscopy and mathematical modeling","volume":"30","author":"Stillhart","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0070","doi-asserted-by":"crossref","first-page":"9528","DOI":"10.1021\/la2011937","article-title":"Real time evolution of liquid crystalline nanostructure during the digestion of formulation lipids using synchrotron small-angle X-ray scattering","volume":"27","author":"Warren","year":"2011","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2017.03.393_bb0075","article-title":"In situ lipolysis and synchrotron small-angle X-ray scattering for the direct determination of the precipitation and solid-state form of a poorly water-soluble drug during digestion of a lipid-based formulation","author":"Khan","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0080","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1002\/jps.23205","article-title":"Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations","volume":"101","author":"Williams","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0085","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/jps.21246","article-title":"Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs","volume":"97","author":"Cuin\u00e9","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0090","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.plipres.2013.04.004","article-title":"Multiscale structures of lipids in foods as parameters affecting fatty acid bioavailability and lipid metabolism","volume":"52","author":"Michalski","year":"2013","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0095","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejps.2013.10.015","article-title":"Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs","volume":"57","author":"Bergstrom","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0100","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1107\/S090904959800137X","article-title":"First performance assessment of the small-angle X-ray scattering beamline at ELETTRA","volume":"5","author":"Amenitsch","year":"1998","journal-title":"J. Synchrotron. Rad."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2008.03.021","article-title":"Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs","volume":"129","author":"Dahan","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.03.393_bb0110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-5173(03)00365-X","article-title":"Improvement of cefpodoxime proxetil oral absorption in rats by an oil-in-water submicron emulsion","volume":"263","author":"Nicolaos","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijpharm.2003.10.036","article-title":"Intestinal absorption of penclomedine from lipid vehicles in the conscious rat: contribution of emulsification versus digestibility","volume":"270","author":"de Smidt","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0120","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s11095-006-9194-z","article-title":"Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs","volume":"24","author":"Cuin\u00e9","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijpharm.2007.09.015","article-title":"Development of a self-emulsifying formulation that reduces the food effect for torcetrapib","volume":"351","author":"Perlman","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0130","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cocis.2009.11.006","article-title":"The influence of emulsion structure and stability on lipid digestion","volume":"15","author":"Golding","year":"2010","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0135","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1208\/s12248-015-9832-7","article-title":"The effect of digestion and drug load on halofantrine absorption from self-nanoemulsifying drug delivery system (SNEDDS)","volume":"18","author":"Michaelsen","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jconrel.2014.07.037","article-title":"\u2018Stealth\u2019 lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug","volume":"192","author":"Feeney","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.03.393_bb0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.carbpol.2010.01.049","article-title":"On the lamellar width distributions of starch","volume":"81","author":"Cardoso","year":"2010","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0150","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/jps.20260","article-title":"Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drug","volume":"94","author":"Kossena","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0155","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jconrel.2011.03.033","article-title":"Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration","volume":"153","author":"Nguyen","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.03.393_bb0160","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejpb.2015.07.015","article-title":"How relevant are assembled equilibrium samples in understanding structure formation during lipid digestion?","volume":"96","author":"Phan","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0165","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejpb.2013.10.016","article-title":"Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: case studies with fenofibrate","volume":"86","author":"Griffin","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0170","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1208\/s12248-014-9589-4","article-title":"In vitro lipolysis data does not adequately predict the in vivo performance of lipid-based drug delivery systems containing fenofibrate","volume":"16","author":"Thomas","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0175","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1152\/ajplegacy.1954.179.1.104","article-title":"Total water content of laboratory animals with special reference to volume of fluid within the lumen of the gastrointestinal tract","volume":"179","author":"Cizek","year":"1954","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1211\/jpp.60.1.0008","article-title":"Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in vivo experiments","volume":"60","author":"McConnell","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0185","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1021\/mp300469m","article-title":"Dynamic analysis of fluid distribution in the gastrointestinal tract in rats: positron emission tomography imaging after oral administration of nonabsorbable marker, [18F]deoxyfluoropoly(ethylene glycol)","volume":"10","author":"Takashima","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0190","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s11095-006-9041-2","article-title":"Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model","volume":"23","author":"Cao","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0195","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0278-6915(00)00136-8","article-title":"Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats","volume":"39","author":"DeSesso","year":"2001","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0200","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/bdd.2510160502","article-title":"Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals","volume":"16","author":"Kararli","year":"1995","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0205","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.2042-7158.2011.01286.x","article-title":"Effect of bile on the oral absorption of halofantrine in polyethylene glycol 400 and polysorbate 80 formulations dosed to bile duct cannulated rats","volume":"63","author":"T\u00f8nsberg","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0210","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1194\/jlr.D800041-JLR200","article-title":"Improved analysis of bile acids in tissues and intestinal contents of rats using LC\/ESI-MS","volume":"50","author":"Hagio","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0215","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijpharm.2013.04.003","article-title":"Bile salts and their importance for drug absorption","volume":"453","author":"Holm","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.03.393_bb0220","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1021\/acs.molpharmaceut.6b00413","article-title":"In vivo precipitation of poorly soluble drugs from lipid-based drug delivery systems","volume":"13","author":"Sassene","year":"2016","journal-title":"Mol. Pharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917304972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917304972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T19:15:03Z","timestamp":1589742903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917304972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":44,"alternative-id":["S0168365917304972"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.03.393","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and in vivo performance of monoacyl phospholipid-based self-emulsifying drug delivery systems","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.03.393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}